Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • COVID-19
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
    • Indexing
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • Home
  • Articles
    • Current Issue
    • COVID-19
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
    • Indexing
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • JABFM On Twitter
  • JABFM On YouTube
  • JABFM On Facebook
Research ArticleOriginal Research

Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study

Matthew J. Labreche, Grace C. Lee, Russell T. Attridge, Eric M. Mortensen, Jim Koeller, Liem C. Du, Natalie R. Nyren, Lucina B. Treviño, Sylvia B. Treviño, Joel Peña, Michael W. Mann, Abilio Muñoz, Yolanda Marcos, Guillermo Rocha, Stella Koretsky, Sandra Esparza, Mitchell Finnie, Steven D. Dallas, Michael L. Parchman and Christopher R. Frei
The Journal of the American Board of Family Medicine September 2013, 26 (5) 508-517; DOI: https://doi.org/10.3122/jabfm.2013.05.120247
Matthew J. Labreche
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grace C. Lee
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell T. Attridge
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric M. Mortensen
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jim Koeller
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liem C. Du
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie R. Nyren
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucina B. Treviño
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvia B. Treviño
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel Peña
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael W. Mann
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abilio Muñoz
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda Marcos
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermo Rocha
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stella Koretsky
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Esparza
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitchell Finnie
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven D. Dallas
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael L. Parchman
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher R. Frei
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Klevens RM,
    2. Morrison MA,
    3. Nadle J,
    4. et al
    . Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763–71.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Klevens RM,
    2. Edwards JR,
    3. Tenover FC,
    4. McDonald LC,
    5. Horan T,
    6. Gaynes R
    . Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003. Clin Infect Dis 2006;42:389–91.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Styers D,
    2. Sheehan DJ,
    3. Hogan P,
    4. Sahm DF
    . Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006;5:2.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Moran GJ,
    2. Krishnadasan A,
    3. Gorwitz RJ,
    4. et al
    . Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–74.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Frei CR,
    2. Miller ML,
    3. Lewis JS 2nd.,
    4. et al
    . Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. J Am Board Fam Med 2010;23:714–9.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Parchman ML,
    2. Munoz A
    . Risk factors for methicillin-resistant Staphylococcal aureus skin and soft tissue infections presenting in primary care: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med 2009;22:375–9.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Stevens DL,
    2. Bisno AL,
    3. Chambers HF,
    4. et al
    . Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373–406.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Liu C,
    2. Bayer A,
    3. Cosgrove SE,
    4. et al
    . Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18–55.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Fridkin SK,
    2. Hageman JC,
    3. Morrison M,
    4. et al
    . Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352: 1436–44.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Forcade NA,
    2. Wiederhold NP,
    3. Ryan L,
    4. Talbert RL,
    5. Frei CR
    . Antibacterials as adjuncts to incision and drainage for adults with purulent methicillin-resistant Staphylococcus aureus (MRSA) skin infections. Drugs 2012;72:339–51.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Eron LJ,
    2. Lipsky BA,
    3. Low DE,
    4. Nathwani D,
    5. Tice AD,
    6. Volturo GA
    ; Expert panel on managing skin and soft tissue infections. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003;52(Suppl 1):i3–17.
    OpenUrlCrossRefPubMed
  12. 12.↵
    US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: uncomplicated and complicated skin and skin structure infections—developing antimicrobial drugs for treatment. July 1998. Available from: http://www.fda.gov/ohrms/dockets/ac/03/briefing/3997B1_02_GFI-Diabetic%20Foot.pdf. Accessed February 9, 2012.
  13. 13.↵
    US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: acute bacterial skin and skin structure infections—developing antimicrobial drugs for treatment. Draft guidance. August 2010. Available from: http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM071185.pdf. Accessed February 9, 2012.
  14. 14.↵
    1. Corey GR,
    2. Stryjewski ME
    . New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good. Clin Infect Dis 2011;52(Suppl 7):S469–76.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Levy BT,
    2. Daly J
    . Community-acquired skin infections in the age of methicillin-resistant organisms. AHRQ Publication No. 11-0007–1-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2010.
  16. 16.↵
    1. Forcade NA,
    2. Parchman ML,
    3. Jorgensen JH,
    4. et al
    . Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med 2011;24:543–50.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Merrill CT,
    2. Elixhauser A
    HCUP fact book no. 6. Hospitalization in the United States, 2002. AHRQ publication no. 05-0056. June 2005. Available from: http://archive.ahrq.gov/data/hcup/factbk6/factbk6.pdf. Accessed March 5, 2010.
  18. 18.↵
    1. Machlin SR
    . Medicare Expenditure Panel Survey (MEPS). Statistical brief #111. Expenses for a hospital emergency room visit, 2003. January 2006. Available from: www.meps.ahrq.gov/mepsweb/data_ files/publications/st111/stat111.pdf. Accessed March 5, 2010.
  19. 19.↵
    1. Machlin SR,
    2. Carper K
    . Medicare Expenditure Panel Survey (MEPS). Statistical brief #166. Expenses for office-based physician visits by specialty, 2004. March 2007. Available from: www.meps.ahrq.gov/mepsweb/data_files/publications/st166/stat166.pdf. Accessed March 5, 2010.
  20. 20.↵
    1. Russo CA,
    2. Owens P,
    3. Steiner C,
    4. Josephsen J
    . HCUP fact book no. 9. Ambulatory surgery in U.S. hospitals, 2003. AHRQ publication no. 07–0007. January 2007. Available from: http://archive.ahrq.gov/data/hcup/factbk9/factbk9.pdf. Accessed March 5, 2010.
  21. 21.↵
    US Department of Labor, Bureau of Labor Statistics. Archived Consumer Price Index detailed report information. Available from: www.bls.gov/cpi/cpi_dr.htm. Accessed November 16, 2011.
  22. 22.↵
    1. Marton JP,
    2. Jackel JL,
    3. Carson RT,
    4. Rothermel CD,
    5. Friedman M,
    6. Menzin J
    . Costs of skin and skin structure infections due to Staphylococcus aureus: an analysis of managed-care claims. Curr Med Res Opin 2008;24:2821–8.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Menzin J,
    2. Marton JP,
    3. Meyers JL,
    4. Carson RT,
    5. Rothermel CD,
    6. Friedman M
    . Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus. Am J Infect Control 2009;38:44–9.
    OpenUrlPubMed
  24. 24.↵
    1. Seaman M,
    2. Lammers R
    . Inability of patients to self-diagnose wound infections. J Emerg Med 1991;9:215–9.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Whitby M,
    2. McLaws ML,
    3. Collopy B,
    4. et al
    . Post-discharge surveillance: can patients reliably diagnose surgical wound infections? J Hosp Infect 2002;52:155–60.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Davis SL,
    2. Delgado G Jr.,
    3. McKinnon PS
    . Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia. Clin Infect Dis 2005;41(Suppl 2):S136–43.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Kuti JL,
    2. Le TN,
    3. Nightingale CH,
    4. Nicolau DP,
    5. Quintiliani R
    . Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral. Am J Health Syst Pharm 2002;59:2209–15.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Ramirez JA,
    2. Bordon J
    . Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. Arch Intern Med 2001;161:848–50.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Mertz D,
    2. Koller M,
    3. Haller P,
    4. et al
    . Outcomes of early switching from intravenous to oral antibiotics on medical wards. J Antimicrob Chemother 2009;64:188–99.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Lee MC,
    2. Rios AM,
    3. Aten MF,
    4. et al
    . Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123–7.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Frazee BW,
    2. Lynn J,
    3. Charlebois ED,
    4. Lambert L,
    5. Lowery D,
    6. Perdreau-Remington F
    . High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005;45:311–20.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Bader MS
    . Diabetic foot infection. Am Fam Physician 2008;78:71–9.
    OpenUrlPubMed
  33. 33.↵
    1. Pallin DJ,
    2. Egan DJ,
    3. Pelletier AJ,
    4. Espinola JA,
    5. Hooper DC,
    6. Camargo CA Jr.
    . Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008;51:291–8.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.
    Alabama Medicaid Agency Average Acquisition Cost (AAC) rate listing for generic drugs: rates effective as of November 9, 2011. Available from: http://al.mslc.com/AACList.aspx. Accessed December 1, 2011.
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 26 (5)
The Journal of the American Board of Family Medicine
Vol. 26, Issue 5
September-October 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
Matthew J. Labreche, Grace C. Lee, Russell T. Attridge, Eric M. Mortensen, Jim Koeller, Liem C. Du, Natalie R. Nyren, Lucina B. Treviño, Sylvia B. Treviño, Joel Peña, Michael W. Mann, Abilio Muñoz, Yolanda Marcos, Guillermo Rocha, Stella Koretsky, Sandra Esparza, Mitchell Finnie, Steven D. Dallas, Michael L. Parchman, Christopher R. Frei
The Journal of the American Board of Family Medicine Sep 2013, 26 (5) 508-517; DOI: 10.3122/jabfm.2013.05.120247

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
Matthew J. Labreche, Grace C. Lee, Russell T. Attridge, Eric M. Mortensen, Jim Koeller, Liem C. Du, Natalie R. Nyren, Lucina B. Treviño, Sylvia B. Treviño, Joel Peña, Michael W. Mann, Abilio Muñoz, Yolanda Marcos, Guillermo Rocha, Stella Koretsky, Sandra Esparza, Mitchell Finnie, Steven D. Dallas, Michael L. Parchman, Christopher R. Frei
The Journal of the American Board of Family Medicine Sep 2013, 26 (5) 508-517; DOI: 10.3122/jabfm.2013.05.120247
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Obesity and Heart Failure as Predictors of Failure in Outpatient Skin and Soft Tissue Infections
  • Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections
  • Transmission and Microevolution of USA300 MRSA in U.S. Households: Evidence from Whole-Genome Sequencing
  • Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
  • Anti-Alpha-Toxin Monoclonal Antibody and Antibiotic Combination Therapy Improves Disease Outcome and Accelerates Healing in a Staphylococcus aureus Dermonecrosis Model
  • Content Usage and the Most Frequently Read Articles by Issue in 2013
  • Patient-Centered Research Happens in Practice-based Research Networks
  • Google Scholar

More in this TOC Section

  • Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing
  • A Cross-Sectional Study of Factors Associated With Pediatric Scope of Care in Family Medicine
  • Social Inequities Between Prenatal Patients in Family Medicine and Obstetrics and Gynecology with Similar Outcomes
Show more Original Research

Similar Articles

Keywords

  • Antibiotics
  • Cost of Illness
  • Epidemiology
  • Infectious Diseases
  • Practice-Based Research
  • Primary Health Care

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us

© 2021 American Board of Family Medicine

Powered by HighWire